Cas:113845-68-4 1-[4-(trifluoromethyl)phenyl]pyrrolidine manufacturer & supplier

We serve Chemical Name:1-[4-(trifluoromethyl)phenyl]pyrrolidine CAS:113845-68-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

1-[4-(trifluoromethyl)phenyl]pyrrolidine

Chemical Name:1-[4-(trifluoromethyl)phenyl]pyrrolidine
CAS.NO:113845-68-4
Synonyms:Pyrrolidine,1-[4-(trifluoromethyl)phenyl]
Molecular Formula:C11H12F3N
Molecular Weight:215.21500
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:3.24000
Exact Mass:215.09200
LogP:3.37060

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Pyrrolidine,1-[4-(trifluoromethyl)phenyl] chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Pyrrolidine,1-[4-(trifluoromethyl)phenyl] physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Pyrrolidine,1-[4-(trifluoromethyl)phenyl] Use and application,Pyrrolidine,1-[4-(trifluoromethyl)phenyl] technical grade,usp/ep/jp grade.


Related News: Soliris, first approved for generalized myasthenia gravis (gMG) in 2017, carries a list price of about $470,000 annually. But to ICER, that cost is “well beyond typical thresholds.” methyl Z-4,4-dimethyl-2,5-diphenyl-5-oxo-2-pentenoate manufacturers in addition to standard therapy. The trial did not meet its primary endpoint based on the SLE Responder Index 4 (SRI4) composite measure. 3-((1E,6E)-7-(tert-butoxycarbonyl)-7-cyano-1,6-heptadien-1-yl)-4-hydroxy-2-butenoic lactone suppliers Officials did, however, acknowledge that there’s growing evidence an extra jab may enhance the antibody response in immunocompromised people. Some small studies suggest up to 50% of people with no antibody response after the authorized regimen of two mRNA jabs developed a response after an additional dose, said CDC’s Sara Oliver, M.D. 4-methoxyphenyl-[1-(2-phenylethyl)-piperidin-4-yl]-amine vendor & factory.